[1. Kamiński K., Obniska J.: Synthesis and anticonvulsant properties of new 1-(2-pyridinyl)- 3-substituted pyrrolidine-2,5-dione derivatives. Acta Pol. Pharm., 65, 457, 2008.]Search in Google Scholar
[2. Lange J. et al.: Synthesis and properties of new cyclic derivatives of succinic acid with anticonvulsant activity. Pharmazie, 32, 82, 1977.10.1002/chin.197728159]Search in Google Scholar
[3. Litchfield J.T., Wilcoxon F.: A simplified method of evaluating doseeffect experiments. J. Pharmacol. Exp. Ther., 96, 99, 1949.]Search in Google Scholar
[4. Löscher W., Fassbender C.P., Nolting B.: The role of technical, biological and pharmacological factors in the laboratory evaluation of anticonvulsant drugs. II. Maximal electroshock seizure models. Epilepsy Res., 8, 79, 1991.]Search in Google Scholar
[5. Łuszczki J.J. et al.: Effects of three N-(carboxyanilinomethyl) derivatives of p-isopropoxyphenylsuccinimide on the anticonvulsant action of carbamazepine, phenobarbital, phenytoin and valproate in the mouse maximal electroshock-induced seizure model. Eur. J. Pharmacol., 648, 74, 2010.10.1016/j.ejphar.2010.08.017]Search in Google Scholar
[6. Łuszczki J.J. et a l.: Inf luence of N-(p-acetylphenyl)-pisopropoxyphenylsuccinimide on the protective action of classical antiepileptic drugs against maximal electroshock-induced seizures in mice. Curr. Issues Pharm. Med. Sci., 26, 76, 2013.10.12923/j.2084-980X/26.1/a.17]Search in Google Scholar
[7. Łuszczki J.J. et a l.: Inf luence of N-hydroxymethyl-pisopropoxyphenylsuccinimide on the anticonvulsant action of different classical antiepileptic drugs in the mouse maximal electroshock-induced seizure model. Epilepsy Res., 100, 27, 2012.10.1016/j.eplepsyres.2012.01.003]Search in Google Scholar
[8. Łuszczki J.J. et al.: No effect of 3-(N-p-isopropoxyphenylsuccinimid omethylamino)-cinnamic acid on anticonvulsant action of different classical antiepileptic drugs in mouse maximal electroshock-induced seizure model. J. Pre-Clin. Clin. Res., 6, 20, 2012.]Search in Google Scholar
[9. Łuszczki J.J., Kocharov S.L., Czuczwar S.J.: Effect of p-isopropoxyphenylsuccinimide monohydrate on the anticonvulsant action of carbamazepine, phenobarbital, phenytoin and valproate in the mouse maximal electroshock-induced seizure model. Pharmacol. Rep., 62, 194, 2010.]Search in Google Scholar
[10. Łuszczki J.J., Kocharov S.L., Czuczwar S.J.: N-(anilinomethyl)-pisopropoxyphenyl- succinimide potentiates the anticonvulsant action of phenobarbital and valproate in the mouse maximal electroshockinduced seizure model. Neurosci. Res., 64, 267, 2009.]Search in Google Scholar
[11. Rogawski M.A., Bazil C.W.: New molecular targets for antiepileptic drugs: alpha(2)delta, SV2A, and K(v)7/KCNQ/M potassium channels. Curr. Neurol. Neurosci. Rep., 8, 345, 2008.10.1007/s11910-008-0053-7]Search in Google Scholar
[12. Stables J.P., Kupferberg H.J. (1997). The NIH Anticonvulsant Drug Development (ADD) Program: preclinical anticonvulsant screening project. In: Molecular and cellular targets for anti-epileptic drugs. Avanzini G., Regesta G., Tanganelli P., Avoli M. (editors). London: John Libbey; p. 191.]Search in Google Scholar
[13. White H.S. et al. (2002). Discovery and preclinical development of antiepileptic drugs. In: Antiepileptic drugs. 5th ed. Levy R.H., Mattson R.H., Meldrum B.S., Perucca E. (editors). Philadelphia: Lippincott Williams & Wilkins; p. 36.]Search in Google Scholar
[14. Zejc A. et al.: Synthesis and anticonvulsant properties of some arylsuccinate methylpyridylimides. Pol. J. Pharmacol. Pharm., 42, 69, 1990.]Search in Google Scholar
[15. Żółkowska D. et al.: Effects of N-(morpholinomethyl)-p-isopropoxyphenylsuccinimide on the protective action of different classical antiepileptic drugs against maximal electroshock-induced tonic seizures in mice. Pharmacol. Rep., 65, 389, 2013.10.1016/S1734-1140(13)71014-4]Search in Google Scholar